Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Nycomed US Inc. Stories

2011-08-01 09:30:00

MELVILLE, N.Y., Aug. 1, 2011 /PRNewswire/ -- Nycomed US Inc. ("Nycomed US") today announced the appointment of Brian A. Markison as President and Chief Executive Officer and member of the Board for what will be the newly created standalone corporation created following the closing of the acquisition of Nycomed A/S by Takeda Pharmaceuticals. The Company also appointed Jeff Bailey to the newly created position of Chief Operating Officer, and John Golubieski as the Chief Financial...

2011-07-11 08:00:00

FLORHAM PARK, N.J., July 11, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today the availability of prescription drug assistance programs to reduce health insurance co-payments for six primary dermatological brands. Under the programs, patients will pay $10 - $30 out-of-pocket for ADOXA® 150mg (doxycycline capsules), APEXICON® E (diflorasone diacetate USP 0.05% [emollient]) CREAM, CUTIVATE® (fluticasone...

2011-05-19 08:00:00

FLORHAM PARK, N.J., May 19, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today that is has launched AK Connect, a patient resource program that contains information tailored to different types of patients about diagnosis, symptoms, treatment and support for actinic keratosis (AK). Now physicians who treat patients with AK have a new resource to help better inform patients about this potentially serious skin condition that affects millions of Americans.(1,2)...

2011-05-19 02:25:00

OSAKA, Japan, and ZURICH, May 19, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis. The boards of directors of each company unanimously approved the transaction which is expected to be completed within 90 to 120 days, making...

2011-05-19 01:34:00

MELVILLE, N.Y., May 19, 2011 /PRNewswire/ -- Nycomed US Inc., a wholly owned subsidiary of Nycomed, announced today that it will become an independent corporation and will no longer be affiliated with Nycomed following the acquisition of its parent company by Takeda Pharmaceutical Company Ltd. Nycomed US will continue to be owned primarily by Nordic Capital Inc, Credit Suisse and Avista Capital Partners, its current private equity owners. The company, founded over 160 years ago, has a...

2011-01-05 08:00:00

FLORHAM PARK, N.J., Jan. 5, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN® (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts (EGWs), has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases (STD) Treatment Guidelines.(1) The new report, developed by the CDC after consultation with a group of...

2010-11-10 12:40:00

MELVILLE, N.Y., Nov. 10, 2010 /PRNewswire/ -- Nycomed US Inc. announced today the appointment of Joseph J. LaRosa as its new Senior Vice President and General Counsel, reporting to Steve Andrzejewski, CEO of Nycomed US. Joe will be the chief legal advisor of the company and oversee all of the company's legal and intellectual property matters. In addition, he will also be responsible for the company's compliance functions. Joe was Vice President, Legal Affairs at Schering-Plough...

2010-08-05 08:00:00

MELVILLE, N.Y., Aug. 5 /PRNewswire/ -- Nycomed US Inc. announced today the appointment of Jeff Wasserstein as its new Sr. Vice President, Business Development and Strategy. Jeff will be responsible for the evaluation and execution of Nycomed US growth strategies to meet US portfolio and financial needs through the execution of in-licensing, acquisitions and out-partnering opportunities. He will report to Steve Andrzejewski, CEO of Nycomed US. Jeff has 20 years experience working in...

2010-07-19 08:00:00

MELVILLE, N.Y., July 19 /PRNewswire/ -- Nycomed US Inc. today announced the appointment of Steve Andrzejewski as the new Chief Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories. Steve Andrzejewski has been working in the pharmaceutical and healthcare industry for more than 20...